FluGen, Inc.
PrivateLast Round
Grant
Jul 1, 2021
Total Funding Raised
$41.8M
Company Overview
FluGen, Inc. is a biotechnology company developing vaccines for influenza and other respiratory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FluGen, Inc. Comparables
Compare FluGen, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vivaldi Biosciences, Inc. | 93% | |
| Osivax | 87% | |
| Blue Lake Biotechnology, Inc. | 82% | |
FluGen, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 1, 2021 | ||||
| Grant | Oct 18, 2017 | ||||
| Series A Extension | Apr 12, 2017 | ||||
| Series A | Aug 25, 2015 | ||||
| VC Round | Feb 21, 2011 | ||||
Angel | May 8, 2008 |
FluGen, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| State of Wisconsin Investment Board | Series A |
| Venture Investors LLC | Series A |
| U.S. Department of War | Grant |
| Knox Equity Group LLC | Series A |
| Wisconsin Alumni Research Foundation | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 26, 2026
Monthly visitors increased 114% MoM, reaching 3.6K.
- Jun 1, 2025
Monthly visitors increased 30% MoM, reaching 1.1K.
FluGen, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about FluGen, Inc.'s valuation, stock price, and market status.